Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One example of...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Human postprandial responses to food and potential for precision nutrition.

Nature medicine·2020
Same author

Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women.

Metabolism: clinical and experimental·2020
Same author

Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.

Gastroenterology·2020
Same author

Aspirin in the Prevention of Colorectal Neoplasia.

Annual review of medicine·2020
Same author

The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment.

Cancer immunology research·2020
Same author

Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.

Clinics in liver disease·2020

Related Experiment Video

Updated: Jul 8, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

A prospective study of aspirin use and the risk for colorectal adenoma.

Andrew T Chan1, Edward L Giovannucci, Eva S Schernhammer

  • 1Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts 02114, USA.

Annals of Internal Medicine
|February 6, 2004
PubMed
Summary
This summary is machine-generated.

Regular aspirin use, particularly higher doses, may lower colorectal adenoma risk. Duration of use showed less impact than dose, suggesting further risk-benefit analysis for general aspirin chemoprevention.

More Related Videos

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jul 8, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

  • Gastroenterology
  • Preventive Medicine
  • Oncology

Background:

  • Established evidence shows regular aspirin use reduces recurrent colorectal adenoma risk.
  • The impact of aspirin dose and duration on primary prevention in average-risk populations remains unclear.

Purpose of the Study:

  • To investigate the effect of aspirin dosage and duration on the primary prevention of colorectal adenoma.

Main Methods:

  • Prospective cohort study within the Nurses' Health Study.
  • Included 27,077 women aged 34-77 without prior adenoma or relevant medical history.
  • Assessed self-reported aspirin use and colorectal adenoma diagnosis via lower endoscopy from 1980-1998.

Main Results:

  • Regular aspirin users (≥2 tablets/week) had a reduced adenoma risk (RR 0.75).
  • A dose-response relationship was observed, with >14 tablets/week showing the greatest risk reduction (RR 0.49).
  • Significant dose-response effects were found for both short-term (<5 years) and long-term (>5 years) use; duration alone did not enhance risk reduction.

Conclusions:

  • Regular, short-term aspirin use is linked to lower colorectal adenoma risk.
  • The most significant protective effect occurred at doses higher than typically recommended for cardiovascular disease prevention.
  • Further evaluation of risks and benefits is needed before recommending aspirin for general population chemoprevention at these doses.